LIFEVANTAGE CORP Increase (Decrease) in Operating Liabilities
LIFEVANTAGE CORP (LFVN) reported Increase (Decrease) in Operating Liabilities of -$662.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2019-10-30
- LIFEVANTAGE CORP increase (decrease) in operating liabilities for the quarter ending 2019-09-30 was -$662.00K.
| Period end | Increase (Decrease) in Operating Liabilities 3 month |
|---|---|
| 2019-09-30 | -$662.00K 10-Q · filed 2019-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |